LONG‐TERM HIGH‐DOSE MEBENDAZOLE FOR CYSTIC HYDATID DISEASE OF LIVER: FAILURE IN TWO CASES
- 1 February 1981
- journal article
- research article
- Published by Wiley in Anz Journal of Surgery
- Vol. 51 (1) , 23-27
- https://doi.org/10.1111/j.1445-2197.1981.tb05897.x
Abstract
Mebendazole was given as definitive therapy to four patients with cystic hydatid disease of the liver who were later explored surgically. Viable hydatid material was removed from two patients after continuous therapy with 40 mg/kg/day for eight and three months respectively. The hydatid material was necrotic in the of her two patients. This drug appeared to be ineffective as definitive treatment of two of these four patients with established hydatid disease of the liver.This publication has 11 references indexed in Scilit:
- In vitro culture of the strobilar stage of Echinococcus granulosus (sheep strain): A review of basic problems and resultsPublished by Elsevier ,2002
- Medical treatment for hydatid disease?BMJ, 1979
- Treatment of hydatidosis.BMJ, 1978
- A Clinical Trial of Mebendazole in the Treatment of Alveolar Hydatid Disease1American Review of Respiratory Disease, 1978
- Treatment of hepatic hydatid disease with mebedazole: preliminary results in four cases.BMJ, 1977
- The permeability of the membranes of experimental secondary cysts of Echinococcus granulosus to [14C]mebendazoleInternational Journal for Parasitology, 1977
- The lethal effect of mebendazole on secondaryEchinococcus granulosus, cysticerci ofTaenia pisiformisand tetrathyridia ofMesocestoides cortiParasitology, 1975
- Mebendazole in enterobiasis. Radiochemical and pilot clinical study in 1,278 subjectsPublished by American Medical Association (AMA) ,1971
- Systematic Search for a Systemic Hydatid ScolicideChemotherapy, 1971
- The development ofEchinococcus granulosuslarvae in laboratory animalsParasitology, 1970